Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
May aid CV risk stratification beyond standard LVH; leaves open prospective validation and therapeutic targeting.
Simone et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: